Mark J. Gergen - 01 Feb 2024 Form 4 Insider Report for Poseida Therapeutics, Inc.

Signature
/s/ Harry J.Leonhardt, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
01 Feb 2024
Net transactions value
-$160,822
Form type
4
Filing time
02 Feb 2024, 20:51:25 UTC
Previous filing
04 Jan 2024
Next filing
04 Mar 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PSTX Common Stock Tax liability $160,822 -47,162 -6.4% $3.41 685,448 01 Feb 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a Restricted Stock Unit Award granted to the Reporting Person on February 1, 2022.